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Cross-presentation plays a fundamental role in the induction of CD8-T cell immunity.
However, although more than three decades have passed since its discovery, surprisingly
little is known about the exact mechanisms involved. Here we give an overview of the com-
ponents involved at different stages of this process. First, antigens must be internalized
into the cross-presenting cell. The involvement of different receptors, method of antigen
uptake, and nature of the antigen can inﬂuence intracellular trafﬁcking and access to the
cross-presentation pathway. Once antigens access the endocytic system, different require-
ments for endosomal/phagosomal processing arise, such as proteolysis and reduction of
disulﬁde bonds. The majority of cross-presented peptides are generated by proteasomal
degradation. Therefore, antigens must cross a membrane barrier in a manner analogous
to the fate of misfolded proteins in the endoplasmic reticulum (ER) that are retrotranslo-
cated into the cytosol for degradation. Indeed, some components of the ER-associated
degradation machinery have been implicated in cross-presentation. Further complicating
the matter, endosomal and phagosomal compartments have been suggested as alterna-
tive sites to the ER for loading of peptides on major histocompatibility complex class I
molecules. Finally, the antigen presenting cells involved, particularly dendritic cell subsets
and their state of maturation, inﬂuence the efﬁciency of cross-presentation.
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CROSS-PRESENTATION: AN OVERVIEW
In the broadest sense, cells contain twodifferent antigenprocessing
pathways that serve to present peptides to T lymphocytes. These
pathways and the machinery required for them have distinct roles
in the immune system and function to sample different environ-
ments for antigenic peptides. Major histocompatibility complex
class I (MHC-I) molecules are loaded in the endoplasmic retic-
ulum (ER) with peptides derived from degradation of cytosolic
proteins by the proteasome, and these MHC-I/peptide complexes
are then surface expressed and presented to CD8+ T cells. MHC-
II molecules exit the ER in association with the invariant chain,
which occupies their peptide binding groove. In the endocytic
pathway proteolysis results in the degradation of the invariant
chain leaving the residual CLIP fragment in the binding groove.
In a process catalyzed by HLA-DM (in humans) CLIP is replaced
by peptides derived by proteolysis from proteins resident or inter-
nalized into the endocytic pathway. After surface expression, these
are presented to CD4+ T cells. Hence, MHC-I generally serves
as a reporter of intracellular infection, while MHC-II senses the
antigens present in the extracellular milieu.
We now know that in professional antigen presenting cells
(APC), peptides derived from exogenously acquired antigens
can be presented on MHC-I. This process is known as cross-
presentation. Furthermore, CD8+ T cells can be primed to such
antigens by dendritic cells (DCs), a process termed cross-priming.
The term was originally introduced to describe CD8+ T cell
sensitization to minor histocompatibility antigens in transplan-
tation situations (Bevan, 1976). The importance of cross-priming
for the generation of CD8+ T cell-mediated immunity in gen-
eral is a topic of debate, but cross-priming certainly plays an
important role during priming of anti-tumor CD8+ T cells as well
as priming the CD8+ response to pathogens which do not directly
infect DCs.
Although various cell types, even including non-professional
antigen-presenting cells like endothelial cells or modiﬁed 293T
cells (Bagai et al., 2005; Giodini et al., 2009), are able to cross-
present under certain conditions, DCs are the most important
cross-presenting cells in vivo (Jung et al., 2002). Inmice, severalDC
subsets are competent for cross-presentation, with the lymphoid-
organ resident CD8α+ DC (Heath et al., 2004; Hildner et al., 2008)
and dermal migratory CD103+ DCs (Bedoui et al., 2009; Henri
et al., 2010) deﬁned as the main cross-presenting DCs. The search
for human counterparts specialized in cross-presentation is ongo-
ing, and considerable progress in characterization of human DC
subsets has been made lately, including the discovery of a likely
equivalent to the mouse CD8α+ DC subset (Villadangos and
Shortman, 2010).
Cross-presentation of exogenous antigens raises interesting and
important biochemical and cell biological questions. How do
internalized proteins that are localized in the endocytic system
gain access to the MHC-I processing and presentation machinery
normally present in the ER? Over three decades have been spent
deﬁning how this process occurs. In a seminal study, Rock and
colleagues demonstrated that presentation of exogenously derived
antigens required proteasomal degradation, and therefore access
to the cytosol (Kovacsovics-Bankowski and Rock, 1995). Consis-
tent with this the ribosomal inhibitor protein gelonin was found
to inhibit protein synthesis when added to cells, demonstrating
that an intact protein can access the cytosol. An alternative mech-
anism, described by Harding and colleagues, involves endosomal
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processing of exogenous antigens and peptide binding to MHC-I
in the endocytic system (Pfeifer et al., 1993). This is known as
the vacuolar pathway. We now know that cross-presentation can
occur through multiple pathways, including antigenic processing
in the endocytic system and/or in the cytosol after translocation
from endosomes or phagosomes. MHC-I binding after cytoso-
lic processing may occur through several different mechanisms.
After antigens reach the cytosol and are degraded by the pro-
teasome, the resulting peptides can be transported into the ER
or phagosomes via the transporter associated with antigen pro-
cessing (TAP), where loading onto MHC-I can occur (Ackerman
et al., 2003; Guermonprez et al., 2003; Houde et al., 2003; Grotzke
et al., 2009). To complicate matters further, recent evidence sug-
gests that peptide transport into phagosomes may involve an as
yet unidentiﬁed, novel, transporter (Merzougui et al., 2011).
Although the broad pathways by which cross-presentation
occurs have been elucidated, only now are more deﬁnitive
molecular studies emerging. Moreover, many questions are still
unanswered. Which cytosolic pathway is most widely used by
cells? What role, if any, do endocytic receptors play in cross-
presentation? How do antigens reach the cytosol? What fac-
tors help achieve the exquisite efﬁciency of this process that
must occur in vivo? Are pathogens able to speciﬁcally inhibit
cross-presentation? How is cross-presentation regulated in DCs?
This review will focus on the known molecular mechanisms of
cytosolic cross-presentation, while the other mechanisms will
be covered by other authors. The second half of the review
concentrates on the role of DC maturation in the context of
cross-presentation.
ANTIGEN UPTAKE BY PROFESSIONAL APC
Early studies of cross-presentation demonstrated that the pro-
cess is not simply a matter of extracellular processing and
cell surface peptide loading (Pfeifer et al., 1993; Kovacsovics-
Bankowski andRock,1995). For particulate antigens, phagocytosis
is required for subsequent cross-presentation, and considerable
evidence suggests that endocytosis is required for soluble anti-
gens. The endocytic pathway ultimately leads to lysosomes and
the phagocytic pathway progresses to phagolysosomes, but exten-
sive proteolysis is incompatible with successful cross-presentation
and a number of papers have implicated early endosomes and
phagosomes in cross-presentation. A key question is whether dif-
ferent receptors deliver cargo preferentially to compartments that
are capable of mediating cross-presentation. Several groups have
shown that during and/or subsequent to phagocytosis, ER compo-
nents are delivered to the phagosome (Ackerman et al., 2003, 2006;
Guermonprez et al., 2003; Houde et al., 2003). A major focus has
been on the role of this process in delivering the components
necessary for translocation of antigenic proteins into the cytosol
(see below), but in fact most or all of the components necessary
for cross-presentation, including MHC-I and the peptide loading
complex (PLC), as well as ER-derived retrotranslocation machin-
ery, are recruited to the phagosome, creating a cross-presentation
competent organelle. Whether delivery of ER components to the
phagosome is required for cytosolic cross-presentation has been
difﬁcult to determine, but at least one study suggests that MyD88
signaling enhances delivery of ER components to endosomes and
that this is required for cross-presentation of soluble ovalbumin
(OVA; Burgdorf et al., 2008).
If phagocytosis of antigens results in the formation of a com-
partment that is competent for cross-presentation, is the ability to
cross-present determined solely by the ability to phagocytose the
antigen? It should be noted that anER contribution to phagosomes
occurs not only in DC, but also in cells that are much less efﬁ-
cient at cross-presentation, such as macrophages (Gagnon et al.,
2002; Houde et al., 2003) and even a normally non-phagocytic
cell line (Giodini et al., 2009). Furthermore, in Dictyostelium, not
only are the ER proteins calnexin and calreticulin recruited to
phagosomes, they appear to be required for phagocytosis (Muller-
Taubenberger et al., 2001). This suggests that ER-recruitment is
an evolutionarily conserved process and not restricted to cells that
can cross-present. Consistent with this, introduction of a phago-
cytic receptor (FcγRIIa) into the non-cross-presenting cell line
HEK293T leads to ER-recruitment to the phagosome and cross-
presentation (Giodini et al., 2009). However, it is difﬁcult to tease
apart the role of receptor-speciﬁc effects and phagocytosis itself.
Moreover, there is experimental evidence demonstrating that
phagocytosis is not always sufﬁcient tomediate cross-presentation,
even in DC (Schnorrer et al., 2006).
Macrophages andDCs express amultitude of cell surface recep-
tors that can mediate endocytosis and phagocytosis, but there is
a dearth of data regarding the role that individual cell surface
receptors and their associated intracellular trafﬁcking and signal-
ing pathways play in the process. Under certain conditions, speciﬁc
receptors such as DEC-205 may induce cross-presentation more
efﬁciently than other receptors such as DC-SIGN (Bozzacco et al.,
2007), but the mechanisms that lead to this superiority have not
been addressed. How could the internalizing receptor inﬂuence
cross-presentation? First, certain receptors could trafﬁc to a spe-
ciﬁc compartment that is highly competent for cross-presentation.
Such a compartment may avoid the decreased pH and increased
proteolysis detrimental for the process (Savina et al., 2006). Sec-
ond, receptors could directly recruit additional components
necessary for cross-presentation. Third, receptors and associated
signaling adaptors could initiate a specialized signaling response
that initiates cross-presentation. These receptor-speciﬁc responses
could also serve to determine whether the cross-presented antigen
promotes tolerance or an active CD8 response. The ability of a
receptor to mediate cross-presentation and cross-priming in vivo
is likely dependent on the antigen and its immunogenic poten-
tial, the delivery mechanism, co-stimulation, and the immune
microenvironment.
The following receptors have been implicated in cross-
presentation: Fc receptors (FcR), scavenger receptors (SR), DC-
SIGN (Dendritic Cell-Speciﬁc ICAM-3 Grabbing NonIntegrin),
MR (Mannose Receptor), DEC-205 (Dendritic and Epithelial
Cells, 205 kDa), CLEC9A (C-type Lectin domain family 9A),
DCIR (DC ImmunoReceptor), and LOX-1 (Lectin-like Oxidized
Low-density Lipoprotein Receptor 1; Regnault et al., 1999;
Bonifaz et al., 2002; Delneste et al., 2002; Berwin et al., 2003;
Shakushiro et al., 2004; Tacken et al., 2005; Burgdorf et al., 2006;
Bozzacco et al., 2007; Sancho et al., 2008, 2009; Klechevsky et al.,
2010). In the case of MR, which internalizes OVA due to man-
nosylation, cross-presentation is dependent on co-ligation of
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TLR4 from contaminating endotoxin and subsequent MyD88
signaling (Burgdorf et al., 2008). Thus, internalization alone is
not necessarily sufﬁcient for cross-presentation, even by profes-
sional APC. Consistent with this, cross-presentation by CLEC9A,
a receptor speciﬁcally expressed on the cross-presentingDC subset
(Sancho et al., 2008), requires a hemITAM motif (containing
only a single YxxL motif) in the cytoplasmic tail and subse-
quent syk signaling for efﬁcient cross-presentation (Sancho et al.,
2009). Notably, CLEC9A is required for recognition, but not
uptake of its physiological ligand (necrotic cells). This suggests
that cross-presentation may use one receptor for antigen uptake
and a different receptor/adaptor protein to trigger the appropriate
pathway in DCs.
The precise mechanisms by which receptor-induced signal-
ing pathways initiate cross-presentation are poorly understood.
In the case of CLEC9A-mediated cross-presentation, syk was
found to associate with the hemITAM motif and be required
for cross-presentation (Sancho et al., 2009). Similarly, cells deﬁ-
cient in FcRγ or DAP12 adaptors, which signal through ITAM
motifs, are deﬁcient in cross-presentation of particulate antigens
(Graham et al., 2007). Although the ITAM present in FcR has not
been reported to be required for cross-presentation, FcR signal-
ing is initiated by ITAM phosphorylation and syk recruitment
(Swanson and Hoppe, 2004). These cases suggest that ITAM or
hemITAM phosphorylation and subsequent syk signaling may
be an important pathway. However, an antigen bound to MR
can be cross-presented even though MR lacks an ITAM motif or
known association with an ITAM-containing adaptor (Burgdorf
et al., 2006). Similarly, the scavenger receptor SR-A1 can mediate
cross-presentationwhile lacking an ITAMor known association of
an ITAM-containing adaptor (C.Wagner and P. Cresswell, unpub-
lished data), and mutation of the hemITAM motif in DC-SIGN
does not affect cross-presentation of OVA bound to latex beads
(C. Wagner and P. Cresswell, unpublished data). Finally, DCIR is
able to cross-present targeted antigen even though it has an ITIM
inhibitory motif (Klechevsky et al., 2010). These data suggest that
there may be a general, unidentiﬁed signaling requirement for
cross-presentation, that receptor-speciﬁc pathways can inﬂuence
cross-presentation, and/or that incorporation of signals frommul-
tiple pathways may determine the fate of internalized antigens.
Identiﬁcation of receptors and associated signaling pathways that
can activate cross-presentation should yield promising candidates
to target formore efﬁcient anti-tumor therapies and anti-pathogen
vaccines.
To date, there is little to no evidence to show that individual
phagocytic receptors impact the recruitment to the phagosome
of additional proteins required for cross-presentation. In the case
of MR-mediated cross-presentation, contaminating endotoxin is
required for TLR4 ligation, MyD88 signaling, and recruitment
of PLC members to endosomes (Burgdorf et al., 2008). Also,
an ITAM signaling pathway not involved in uptake of bead- or
bacteria-associated antigens was shown to be required for recruit-
ment of NOX2 to phagosomes and efﬁcient cross-presentation
(Graham et al., 2007). These data suggest that recruitment of fac-
tors that enhance cross-presentation is determined not by the
phagocytic receptor, but more likely by co-ligation of a second
receptor.
ANTIGEN UNFOLDING AND CYTOSOLIC TRANSLOCATION
One of the more intriguing and perplexing questions about cross-
presentation is how antigens access the cytosol. After initial studies
showed that the proteasome is required formost examples of cross-
presentation, with the underlying assumption that this reﬂects
cytosolic proteolysis, how antigens cross the phagosomal mem-
brane has been a major topic of study. A major leap forward was
the ﬁnding that at least some of the machinery that functions in
ER-associated degradation (ERAD), which translocates unfolded
proteins from the ER lumen to the cytosol for degradation
(Vembar and Brodsky, 2008), is localized to phagosomes in APCs
and facilitates antigen translocation to the cytosol (Guermonprez
et al., 2003; Houde et al., 2003; Imai et al., 2005; Ackerman et al.,
2006). Recently it has been found that the ER–Golgi intermediate
compartment (ERGIC) SNARE protein Sec22b is required for the
process (Cebrian et al., 2011).When Sec22b functionwas inhibited
using RNAi, DCs were much less efﬁcient in translocating anti-
gens to the cytosol. However, the components involved in antigen
translocation to the cytosol and whether the nature of the antigen
inﬂuences the process remain unclear. It is also unclear if there
are specialized components of the retrotranslocation machinery
in the phagosome and cytosol that function in cross-presentation
but not in ERAD. Other open questions are whether there is a
speciﬁc time window in which the retrotranslocation machinery
is localized to phagosomes/endosomes, and whether the process is
regulated by factors such as thematuration state of the cell or iden-
tity of the internalizing receptor. Also, as is the case with ERAD,
the nature of the channel through which antigens are translocated
remains a subject of debate.
Cells devote considerable energy to the production of secre-
tory proteins. Not all of these proteins fold correctly and therefore
need to be degraded before they are allowed to accumulate in
the ER. Cells contain a structured complex of proteins that func-
tions constitutively in the ER to facilitate degradation of misfolded
proteins, i.e., ERAD. ERAD requires chaperones that recognize
terminally misfolded proteins, a translocation channel, ubiquiti-
nation machinery, deglycosylating enzymes, and other accessory
proteins (Vembar and Brodsky, 2008). In mammalian and yeast
cells, the ERAD complex forms around a central E3 ubiquitin
ligase, whose identity differs depending on the aberrant pro-
tein (Kostova et al., 2007). In mammalian cells, the most widely
studied E3 ligases involved in ERAD are hrd1 and gp78, which
function in the translocation of a number of ERAD substrates.
Once a protein is identiﬁed as misfolded and targeted to the
retrotranslocation channel it can be ubiquitinated during translo-
cation, targeting it for degradation. After the substrate has partially
entered the cytosol, the AAA ATPase VCP/p97 (cdc48 in yeast)
generally functions to extract it into the cytosol (Ye et al., 2001;
Braun et al., 2002; Jarosch et al., 2002; Rabinovich et al., 2002).
The cytosolic chaperone hsp90 (Taylor et al., 2010), or even pro-
teasomes themselves (Mayer et al., 1998; Lee et al., 2004; Lipson
et al., 2008), have been proposed to mediate the dislocation event
for substrates which are not dependent on p97. Overall, the
function of ERAD is translocating misfolded proteins across a
membrane and targeting them for proteasomal degradation before
their accumulation results in induction of the unfolded protein
response.
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The process of ERAD is very similar to antigen translocation
into the cytosol for cross-presentation. Initial studies demon-
strated that one potential retrotranslocation channel, sec61, is
localized to phagosomes and that ubiquitinated proteins and pro-
teasomes are associated with phagosomes (Guermonprez et al.,
2003; Houde et al., 2003). Furthermore, ERAD components such
as sec61, p97, and Bip can be co-immunoprecipitated with exoge-
nously added OVA and vice versa (Imai et al., 2005). Together,
these data suggest that the factors necessary for retrotransloca-
tion are accessible to internalized antigens, even if the nature
of the retrotranslocation channel(s) is unclear. The presence of
functional retrotranslocation machinery has been conﬁrmed by
our laboratory and others. After internalization of latex beads
and luciferase by a DC-like cell line and subsequent phago-
some puriﬁcation, translocation of phagosomal luciferase across
the membrane requires addition of cytosol or recombinant p97
(Ackerman et al., 2006), demonstrating that p97 can function in
phagosomal translocation as well as ERAD. Moreover, knock-
down of p97 function by either expression of a dominant negative
mutant or by siRNA inhibits cross-presentation (Imai et al., 2005;
Ackerman et al., 2006). In addition to p97, hsp90 has also been
implicated in both retrotranslocation and cross-presentation.
Cells deﬁcient in Hsp90α by knockout, siRNA knockdown, or
pharmacological inhibition show decreased cross-presentation of
soluble or cell-associated OVA (Ichiyanagi et al., 2010). Hsp90 can
contribute to antigen translocation to the cytosol (Imai et al., 2011)
or to cytosolic refolding of proteins after translocation (Giodini
and Cresswell, 2008).
Although ERAD components are recruited to phagosomes
from the ER as described above, other mechanisms may con-
tribute to recruitment of ERAD components in the case of
endosomes. Mannose receptor ligation by OVA results in polyu-
biquitination of the receptor leading to increased recruitment of
p97, OVA translocation to the cytosol, and cross-presentation
(Zehner et al., 2011). Poly- but not mono-ubiquitination was
required for the recruitment of p97 and OVA translocation to
the cytosol, suggesting that receptor ubiquitination can serve to
recruit cytosolic components required for antigen dislocation.
As p97 can directly interact with members of the retrotranslo-
cation complex (Zhong et al., 2004; Li et al., 2005; Schulze et al.,
2005; Ye et al., 2005; Morreale et al., 2009), which must already
be localized to endosomes for translocation to occur, it is unclear
why receptor polyubiquitination is required for this recruitment.
However, the retrotranslocation complexes present in phago-
somes and endosomes are still ill-deﬁned and this may be a
mechanism governing the ability of certain receptors to mediate
cross-presentation.
The retrotranslocation of exogenously added antigens has been
difﬁcult to study due to the lack of a good readout for their
access to the cytosol. Studies have relied on the use of tox-
ins such as gelonin or exotoxin A (exoA) from Pseudomonas
aeruginosa (Kovacsovics-Bankowski and Rock, 1995; Ackerman
et al., 2006; Giodini and Cresswell, 2008; Giodini et al., 2009),
enzymes such as HRP (Gil-Torregrosa et al., 2004), cytochrome c
(Lin et al., 2008) or luciferase (Giodini and Cresswell, 2008), or
pulsing large amounts of soluble OVA onto cells and exami-
nation of OVA in the cytosolic fraction (Burgdorf et al., 2008;
Imai et al., 2011). No assay system for tracing particulate anti-
gens has been devised yet, and all of these methods using soluble
antigens have their drawbacks. In the case of exoA, there is evi-
dence demonstrating that exoA can inhibit retrotranslocation of
radioactive-labeled peptides from microsomes (Koopmann et al.,
2000). ExoA has also been shown to inhibit cross-presentation
of soluble proteins and immune complexes as well as inhibit
presentation of bacterially and parasite-derived antigens (Ack-
erman et al., 2006; Giodini et al., 2009; Goldszmid et al., 2009;
Grotzke et al., 2009). However, the target of inhibition remains
unknown. When pulsing enzymes or large amounts of protein
antigen onto cells, a common problem is that protein or enzy-
matic activity found in the cytosol could be due to contamination
during processing or lysosomal “bursting” and not true retro-
translocation. Until an assay is developed that directly measures
retrotranslocation, results need to be interpreted with caution.
During ERAD, many substrates are unfolded before translo-
cation to the cytosol. If cross-presentation utilizes the same
retrotranslocationmachinery as ERAD, then cross-presented anti-
gen should also be unfolded before translocation. Indeed, several
reports have shown a requirement for acidiﬁcation or partial
lysosomal proteolysis of antigens that are cross-presented in a
proteasome-dependent manner (Fonteneau et al., 2003; Giodini
et al., 2009), suggesting that processing of the internalized protein
or at least breakdown of immune complexes or apoptotic cells
are required prior to translocation. Chaperones such as calnexin,
calreticulin, Bip, and the ER enzyme protein disulﬁde isomerase
(PDI), have all been shown to localize to phagosomes and may
play a role in protein unfolding (Ackerman et al., 2003; Guermon-
prez et al., 2003; Houde et al., 2003; Imai et al., 2005). For the case
of ERAD substrates containing disulﬁde bonds, several studies
demonstrate that reduction is required for, or enhances, retro-
translocation (Molinari et al., 2002; Dong et al., 2008; Ushioda
et al., 2008). Similarly, for cross-presented antigens with disul-
ﬁde bonds, it is likely that reduction and unfolding is required
for cytosolic access. The only known thiol reductase present in
phagosomes and lysosomes prior to ER acquisition is γ-interferon
inducible lysosomal thiol reductase (GILT). GILT-deﬁcient DC are
deﬁcient in their ability to cross-present gB, a HSV-1 glycoprotein
that contains ﬁve disulﬁde bonds, but showed no defect in cross-
presentation of a protein that did not contain disulﬁde bonds
(Singh and Cresswell, 2010). Furthermore, GILT-deﬁcient mice
showed a decrease in cross-priming anti-gB and anti-inﬂuenza-
speciﬁc CD8+ T cells. These results underscore the importance
of protein unfolding for cross-presentation, and demonstrate
that further characterization of the mechanisms that aid protein
unfolding while at the same time limiting lysosomal proteolysis
are needed.
CROSS-PRESENTATION IN THE CONTEXT OF DC
MATURATION
The ability to cross-present not only differs between various
cell types or DC subsets, but the maturation state of the cross-
presenting DCs also plays an important role. Microbial products,
inﬂammatory cytokines or mediators of tissue damage induce a
process of maturation in DCs that, besides changes in phenotype
and motility, also involves changes in handling and presentation
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of antigens. These modiﬁcations signiﬁcantly affect MHC-II-
restricted presentation, but also inﬂuence cross-presentation.
Maturation is a potentially attractive approach to dissecting the
molecular mechanisms regulating cross-presentation. However,
care needs to be taken to separate effects on T cells resulting from
enhanced co-stimulation from a true effect on the formation of
MHC-I/peptide complexes.
Depending on the timing there are different scenarios for
how DC maturation may affect cross-presentation. One can ask
how DC activation affects cross-presentation of antigens that are
acquired together with or shortly prior to the maturation event,
such as antigens acquired from virally infected cells. Experimen-
tally this may be represented by the administration of a deﬁned
antigen followed by or combined with speciﬁc ligand for innate
immune receptors, such as Toll-like receptors (TLRs). Alterna-
tively one can ask if DCs are still able to cross-present antigens that
they encounter in an already matured state. This would be impor-
tant in a situation in which an individual encounters a pathogen
while already undergoing a response to prior infection. We will
discuss the latter situation ﬁrst.
CROSS-PRESENTATION IN MATURE DCs
A rationale for cross-presentation being controlled through mat-
uration comes from analogy to presentation on MHC-II. Both
cross-presentation andMHC-II presentation serve to prime T cell
responses, with antigens presented by either MHC-I to CD8+ T
cells or to CD4+ T cells via MHC-II. MHC-II-restricted antigen
presentation is tightly regulated during maturation at several lev-
els, including alterations in endocytic proteolysis, re-distribution
of peptide loaded MHC-II molecules to the cell surface, enhanced
stability of surface complexes and reductionofMHC-II biosynthe-
sis (Wilson andVilladangos, 2005).With few exceptions (Drutman
and Trombetta, 2010; Platt et al., 2010), these maturation-induced
changes generally prevent MHC-II presentation of antigens by
mature DCs. The proposed beneﬁt is preservation of theMHC-II/
peptide complexes derived from antigens acquired at the onset of
maturation (Villadangos et al., 2005). A pathogen-derived antigen
that is acquired in the periphery by immature DCs will still be
presented by mature DCs that have migrated to lymph nodes to
prime CD4+ T cells.
For cross-presentation, the situation is more complex. There
is a considerable overlap with pathways used simultaneously for
endogenous MHC-I presentation, a process that is still opera-
tional in mature DCs (Gil-Torregrosa et al., 2004; Wilson et al.,
2006). Supporting this notion, MHC-I synthesis and trafﬁck-
ing is not subjected to the same control during maturation as
MHC-II. MHC-I synthesis is increased during maturation (Cella
et al., 1997; Rescigno et al., 1998) and stability is not affected (Cella
et al., 1997; Delamarre et al., 2003) or is only moderately affected
(Ackerman and Cresswell, 2003). One could argue that cross-
presentation should still be operational in mature DCs to allow
initiation of responses toward secondary pathogens, although the
relatively short lifespan of matured DCs and the constant renewal
by fresh immature DCs could take care of that problem (Kamath
et al., 2002). If cross-presentation is indeed regulated by matura-
tion in order to focus or preserve certain antigens, what could
be the mechanism? Exogenous material taken up at the onset
of maturation may be retained intracellularly until the mature
DC reaches the lymph node, creating a form of antigenic mem-
ory. In mouse DC-like cell lines and to some extent in bone
marrow DCs, storage of soluble (Lutz et al., 1997) or immune
complexed antigens (van Montfoort et al., 2009) in distinct com-
partments with reduced proteolytic activity has been observed,
either in immature DCs (Lutz et al., 1997) or in mature DCs
(van Montfoort et al., 2009). Whether specialized storage com-
partments for exogenous antigens exist in all cross-presenting
DCs is unknown. Also unknown is how antigen deposition and
release are regulated. In a human DC-like cell line trafﬁck-
ing of MHC-I molecules to the cell surface was delayed in an
immature state, suggesting that intracellular retention of pre-
formed MHC-I/peptide complexes may occur (Ackerman and
Cresswell, 2003).
Regardless of theoretical considerations, published evidence
does not clearly argue for or against regulation of cross-
presentation during maturation. As often, the truth may lie
somewhere in between: cross-presentation in mature DCs may
be compromised under certain circumstances, depending on the
maturation stimulus and the nature or the form of the antigen
that is encountered. With a few exceptions, studies have employed
the OVA antigen to study the effect of maturation on cross-
presentation. It should be noted that bone marrow-derived DCs
require an additional maturation stimulus during or shortly after
antigen uptake to cross-present soluble OVA (Delamarre et al.,
2003; Gil-Torregrosa et al., 2004). Depending on the study, pre-
treatment of DCs with certain TLR ligands such as CpG, LPS, or
poly (I:C), either did not alter or enhanced cross-presentation of
subsequently acquired antigens (Regnault et al., 1999;Machy et al.,
2000; Datta et al., 2003; Henri et al., 2007; Weck et al., 2007; Drut-
man and Trombetta, 2010; Platt et al., 2010). On the other hand,
the ability to cross-present can also be lost after contact with TLR
ligands, both after administration in vivo (Wilson et al., 2006) as
well as after prolonged treatment of DCs in vitro (Gil-Torregrosa
et al.,2004;Weck et al.,2007).We found that peptidoglycan, a com-
mon impurity in LPS preparations, can inhibit cross-presentation
of viral antigens via signaling through cytoplasmic NOD receptors
(Wagner and Cresswell, 2012).
Decreased antigen uptake (Gil-Torregrosa et al., 2004; Wilson
et al., 2006;Weck et al., 2007) and a lack of transfer of antigen to the
cytosol (Gil-Torregrosa et al., 2004) have been proposed to explain
reduced cross-presentation by mature DCs. Decreased uptake is
likely a contributing factor but cannot be the sole explanation, as
mature DCs still take up considerable amounts of antigens, even if
reduced compare to immature DCs (Datta et al., 2003; Drutman
and Trombetta, 2010; Platt et al., 2010; Wagner and Cresswell,
2012; C. Wagner and P. Cresswell, unpublished data). In vivo,
antigen availability is certainly also a regulatory factor. For exam-
ple, immature DCs residing in the periphery may have access
to pathogen-derived antigens at a local site of infection, unlike
mature DCs that have already migrated to the lymph node and
never come in contact with the new antigen. Regarding inhibition
of antigen transfer to the cytosol, it would be very interesting to
understand exactly how this process is impaired in mature DCs.
Are the antigens routed to different compartments that lack com-
ponents of the still unidentiﬁed transport machinery? Are the
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antigens degraded within endosomal/lysosomal compartments
before they can be retrotranslocated? These are potential lev-
els of regulation that are speciﬁc for cross-presentation and
would not interfere with endogenous MHC-I peptide loading and
presentation.
PHAGOSOME MATURATION AND ANTIGEN DEGRADATION
Major contributions to our understanding of cross-presentation
came from a series of studies on the regulation of proteolysis
and pH in DCs. DCs have a lower content of lysosomal pro-
teases compared to macrophages (Delamarre et al., 2005) and
the kinetics of acquisition of distinct proteases during phago-
some maturation are slower in DCs than macrophages (Lennon-
Dumenil et al., 2002). Amigorena and co-workers demonstrated
that, unlike macrophages, DCs limit acidiﬁcation in phagosomes
and inhibit proteolysis, thus promoting cross-presentation (Savina
et al., 2006). DCs maintain pH levels above pH 7 for several hours
post-phagocytosis (Savina et al., 2006), in contrast tomacrophages
where the pH drops to pH 5 within 15 min (Yates et al., 2005). The
mechanism involves recruitment of the NADPH oxidase NOX2
to the phagosome, which drives alkalinization of the phagoso-
mal lumen and is recruited in a Rab27-dependent fashion (Savina
et al., 2006; Jancic et al., 2007). In CD8α+ DC, the GTPase Rac2
is responsible for assembly of the NOX2 complex on phagosomes,
while Rac1 directs NOX2 to the plasma membrane in CD8α−
DC (Savina et al., 2009). A high pH would serve to limit prote-
olysis and thus favor cross-presentation. An elevated pH might
also contribute in other ways to successful cross-presentation,
such as inﬂuencing the conformation of proteins associated with
translocation of antigens or proper assembly of the PLC.Although
limited acidiﬁcation may facilitate cross-presentation, a certain
degree of proteolysis is necessary for pre-processing particulate
antigens before translocation into the cytosol or for complete
processing of antigens in case of the vacuolar pathway of cross-
presentation. DCs may selectively use proteases active at a higher
pH than most lysosomal proteases. One example is cathepsin S
(Kirschke et al., 1989) which is enriched inDCs (Lennon-Dumenil
et al., 2002) and has been shown to be involved in process-
ing of antigens for the vacuolar pathway of cross-presentation
(Shen et al., 2004).
Dendritic cell activation has been demonstrated to modify
phagosome maturation and proteolysis. The assembly of the
vacuolar proton pump in lysosomes is enhanced after activa-
tion with LPS, resulting in enhanced acidiﬁcation and higher
protein degradation (Trombetta et al., 2003), while phagocyto-
sis induction combined with LPS treatment of DCs was found
to delay acquisition of active proteases by phagosomes (Lennon-
Dumenil et al., 2002). This could mean that despite an overall
enhancement of lysosomal activity after TLR4 triggering, pro-
teolytic activity in phagosomes is actually reduced, potentially
preserving antigens for cross-presentation. However, the latter
study was based on a method using internalized beads coated
with probes speciﬁc for cysteine proteases, and LPS-treated DC
tend to be “sticky” and immobilize beads at the cell surface. Sur-
face bound beads could potentially lead to an overestimation
of initial uptake compared to untreated DC and also result in
a mixed population of phagosomes, due to slow internalization
of the surface bound beads over time (C. Wagner and P. Cress-
well, unpublished data). Two further reports link NOX2 activity
to TLR signaling and efﬁcient intracellular bacterial killing: in
human DC, NOX2 activity was increased in TLR ligand matured
DCs (Vulcano et al., 2004), and in macrophages, NOX2 assem-
bly was regulated by MyD88, a central adaptor protein for TLR
signaling (Laroux et al., 2005). Thus, TLR signaling appears to
regulate cross-presentation by modulating NOX2 activity and
phagosomal pH.
CROSS-PRESENTATION OF ANTIGENS COMBINED WITH
MATURATION STIMULI
How does maturation that occurs simultaneously with or after
antigen uptake relate to the ability to cross-present? CD8α− cells,
which are inferior to CD8α+ DCs in terms of cross-presentation,
can be activated through FcγR triggering and become compe-
tent for cross-presentation of immune complexes (den Haan and
Bevan, 2002). Besides immune complexes (Regnault et al., 1999;
den Haan and Bevan, 2002), cross-presentation can be induced by
certain stimuli such as LPS (Gil-Torregrosa et al., 2004;West et al.,
2004), disruption of cell contacts, or CD40L stimulation (Dela-
marre et al., 2003), but not by CpG (Datta et al., 2003; Delamarre
et al., 2003), low-dose LPS, Poly (I:C), or TNFα (Delamarre et al.,
2003). This means that OVA cross-presentation is induced by only
a subset of maturation conditions that stimulate MHC-II presen-
tation. Cross-presentation of physiological relevant antigens, such
as viral proteins from infected cells, may have different require-
ments formaturation stimuli. These antigens are already delivered
in a complex mix of activating signals, such as pathogen-derived
TLR ligands and signals from dying cells. Under experimental
settings, no additional external maturation stimuli are needed to
induce cross-presentation.
What mechanisms are responsible for maturation-induced
changes in cross-presentation? Early after activation, DCs tran-
siently sequester endogenous ubiquitinated proteins in cytosolic
aggregates, termed DALIS by Pierre and colleagues, a phe-
nomenon proposed to favor the processing of internalized exoge-
nous antigens for cross-presentation (Lelouard et al., 2004). It
has been proposed that cross-presentation involves early endo-
somal compartments (Burgdorf et al., 2008; Di Pucchio et al.,
2008; Belizaire and Unanue, 2009). During maturation, changes
in phagosomal/endosomal routing could potentially also alter
the fate of antigens. Blander and Medzhitov (2006b) pro-
posed that the presence of a TLR ligand with an antigen in
a phagosome favors MHC-II processing. Only antigens from
phagosomes with TLR triggering are efﬁciently routed to lyso-
somes where invariant chain processing occurs. This offers a
solution to the problem how an antigen-presenting cell would
ensure that only harmful antigens and not phagocytosed self-
antigens are presented to T cells. For cross-presentation, one
could speculate that the effect would be the opposite, i.e., that
TLR-dependent shufﬂing toward lysosomal degradation would
impair efﬁcient cross-presentation. It has also been reported that
TLR signaling inﬂuences phagosome maturation in macrophages
(Blander and Medzhitov, 2004). However, Russell and col-
league were unable to detect TLR2 or TLR4-dependent regulation
of phagosome maturation (Yates and Russell, 2005). Potential
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explanations for the discrepancy have been discussed by the
authors (Blander and Medzhitov, 2006a; Russell and Yates,
2007). Another study showed that TLR stimulation recruits
components of the autophagy pathway to phagosomes, result-
ing in enhanced phagosome maturation (Sanjuan et al., 2007).
The latter three studies on TLR-dependent phagosome matu-
ration have used macrophages and not all ﬁndings may apply
to DCs.
Finally, maturation signals alone do not determine the cross-
presentation ability of a DC. There are many subsets of peripheral
DCs that mature after encounter of antigen and migrate to
lymph nodes, yet only a specialized subset, deﬁned by the
expression of CD103+ (Bedoui et al., 2009; Henri et al., 2010)
can cross-present with high efﬁciency. A particular transcrip-
tional proﬁle is likely to be responsible for this, because migra-
tory CD103+ DCs are very similar to cross-presenting lymph
node-resident CD8a+ DCs, sharing the marker XCR1 (Crozat
et al., 2011).
CONCLUDING REMARKS
Understanding how maturation affects cross-presentation in vitro
and in vivo is important for vaccination strategies and other
immunotherapies, where the induction of maturation is a pre-
requisite for eliciting an effective T cell response. In addition,
dissecting which factors inﬂuence the ability to cross-present dur-
ing maturation will advance our understanding of the molecular
process of cross-presentation. Studying maturation in vitro allows
one to work with one cell type under deﬁned conditions, where
the modiﬁcation of a single parameter, such as the addition of a
TLR ligand, changes the outcome of cross-presentation. However,
any advances obtained from in vitro systems need to be veriﬁed in
more complex in vivo settings, a step where knockout animals have
proven to be an invaluable tool. Models using infectious agents
that can subvert antigen processing pathways will also contribute
to our understanding. Last but not least, having the necessary
reagents and readouts to follow antigens other thanOVA is amajor
requirement for further progress.
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